About Xpress Biologics
Xpress Biologics is a company based in Liege (Belgium) founded in 2014 was acquired by Polyplus Transfection in December 2022.. The company has 51 employees as of December 31, 2022. Xpress Biologics offers products and services including Recombinant Protein Manufacturing, Plasmid DNA Manufacturing, Antibody Fragment Manufacturing, and Development of Analytical Tools. Xpress Biologics operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Liege, Belgium
- Employees 51 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xpress Biologics
-
Annual Revenue
-
Net Profit
$-916.94 K (USD)-1557as on Dec 31, 2022
-
EBITDA
$-92.07 K (USD)-115as on Dec 31, 2022
-
Latest Funding Round
-
Investors
Polyplus Transfection
& 1 more
-
Employee Count
51
as on Dec 31, 2022
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xpress Biologics
Xpress Biologics offers a comprehensive portfolio of products and services, including Recombinant Protein Manufacturing, Plasmid DNA Manufacturing, Antibody Fragment Manufacturing, and Development of Analytical Tools. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops and produces recombinant proteins for research and clinical use.
Produces plasmid DNA for vaccine and therapeutic applications.
Manufactures antibody fragments for diagnostics and treatments.
Creates tools for quality control in biologics production.
Funding Insights of Xpress Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Xpress Biologics
Xpress Biologics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Polyplus Transfection and ARCHIMED. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare industries are funded and supported globally by ARCHIMED.
|
Founded Year | Domain | Location | |
|
Transfection Solutions for Healthcare and Life Sciences organizations
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xpress Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Xpress Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xpress Biologics Comparisons
Competitors of Xpress Biologics
Xpress Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for microbiome based diseases
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Xpress Biologics
Frequently Asked Questions about Xpress Biologics
When was Xpress Biologics founded?
Xpress Biologics was founded in 2014.
Where is Xpress Biologics located?
Xpress Biologics is headquartered in Liege, Belgium. It is registered at Liege, Liege, Belgium.
How many employees does Xpress Biologics have?
As of Dec 31, 2022, the latest employee count at Xpress Biologics is 51.
What does Xpress Biologics do?
Xpress biologics is a contract research organisation offering services in the following areas designing of protein purification system (bacteria and yeasts), process development and manufacturing of new biologics (recombinant proteins, antibody fragments, and plasmid DNA), biosimilars and biobetters, and the management of the pre-clinical and clinical trials management of the GMP manufacturing. The company provides these services to human and veterinary healthcare markets and diagnostic markets. Additionally, the company also provides services in analytical testing.
Who are the top competitors of Xpress Biologics?
Xpress Biologics's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Xpress Biologics offer?
Xpress Biologics offers Recombinant Protein Manufacturing, Plasmid DNA Manufacturing, Antibody Fragment Manufacturing, and Development of Analytical Tools.
Who are Xpress Biologics's investors?
Xpress Biologics has 2 investors. Key investors include Polyplus Transfection, and ARCHIMED.